The Anatomy of Premium Escalation: Rethinking Malaysia’s Healthcare Financing Model (Part II)

By Sean Thum, Nadirah Babji, Dinesh Sangarran Ramachandram, Dinyadarshini Johnson, Yogarabindranath Swarna Nantha, 17th March 2026

“Every system is a lie refined by logic” – Emile Cioran

RESET of the current system

The current administration’s RESET initiative seeks a more incremental approach. A key proposal is the introduction of a standardised basic medical and health insurance/takaful (MHIT) product (the Base MHIT Plan) targeted for implementation in 2027. By creating a common benchmark for basic medical coverage, policymakers aim to broaden risk sharing while improving comparability across insurers and takaful operators. This initiative is widely regarded as remarkably positive, primarily because standardization – if executed properly – could reduce product complexity, minimise benefit arbitrage, and stabilise pricing expectations.  

Notably – occurring simultaneously in what seems to be a two-pronged approach – the policy also aims at a reconfiguration in reimbursement methodology from fee-for-service to Diagnosis-Related Groups (DRGs). Conceptually, by incentivizing providers through a fixed payment per episode of care, DRGs realign incentives toward efficiency. This shift remunerates hospitals for managing cases within predictable cost bands rather than maximizing procedural volume. In Malaysia, where the system is currently prone to volume-driven inflation, this significant structural pivot is not only timely but valuable. 

Not Everything Is Quiet on the RESET Front

That being said, DRGs are not exactly a panacea for rejuvenating a system under strain. International experience warns that behavioural adaptation to such payment reforms may undermine its intended effectiveness. For example, the act of “upcoding” (i.e., classifying patients into higher-paying diagnostic categories) can inflate reimbursements without improvements to the expected quality of care. Moreover, especially when much needed safeguards are not in place, these reforms also run the   unleashing compensatory actions such as premature patient discharge or “defensive” case selection. Without strong clinical audit mechanisms, unified interoperability between data systems, and independent oversight, payment reform can quickly degenerate into a merely accounting exercise instead of a value-based transformation. 

Beyond provider payment reform, the insurance architecture itself raises parallel design concerns. Of particular interest is the proposed coverage cap under the Standard plan of the Base MHIT scheme (RM100,000–RM150,000) with the higher-limit Standard-Plus option incorporates substantial deductibles. Together, these design features may shift residual financial risk back to households. The risk-rated premiums and enrolment caps at age 70 also concentrate burden on older adults and those with chronic illness. These design tensions signal why reforms must extend beyond product standardization toward deliberate structural redesign anchored in sufficient fiscal commitment and executed with clarity, credibility, and long-term resolve.

In a nutshell, RESET hits all the right buttons in terms of defining the architecture of payment. But banking on architecture alone glosses over the need for a holistic approach and cannot stabilize a system under demographic and epidemiological pressures. If Malaysia aspires to move beyond cyclical premium crises and reactive subsidies, reform must extend upstream into primary care strengthening, risk pooling expansion, and price transparency. 

Putting the best foot forward

Against this backdrop, the priority may be interpreted as one of systemic alignment. An enduring solution must address both the financing architecture and the clinical drivers of cost. Payment reform without delivery reform will simply be dead in the water. On the flipside, cost containment without prevention will only result in a temporary reprieve to a crisis that is now slowly progressing into an almost immutable crisis. 

Recalibration into a primary care model first

Long overdue is a revamp of the predominantly hospital-centric care and a transparent transition into a primary care led model. The evidence is undeniable - systems powered by primary care consistently score lower total health expenditure and improved health outcomes (BMJ Global Health, 2025). For any reforms to even see the light of day, the deal breaker (and often proverbial battleground or flash point) hinges squarely on an earnest and transparent integration of general practice across Malaysia’s public–private divide. This is a Gordian knot that must be untied without prejudice or ideological entrenchment. It is a non-negotiable prerequisite to any meaningful payment reform in the nation

Both public and private general practitioners must be meaningfully integrated into structured a cross- referral network and incentivized to function as gatekeepers, particularly in chronic disease management. Shared autonomy is key. Here, it is important to emphasize that the strengthening of primary care services does not rest solely upon general practitioners. Effective stewardship must transcend disciplinary silos and hierarchical tensions; primary care reform cannot rely on physicians alone. The systematic delegation of appropriate clinical responsibilities to trained nurses, psychologists, pharmacists, and allied health professionals—commonly termed task shifting—must form a core component of reform. Routine monitoring of stable individuals living with diabetes, blood pressure titration, medication counselling, and lifestyle coaching need not be specialist-driven, nor even physician-exclusive in every instance. When properly protocolized and supported by interoperable electronic medical records, such delegation expands system capacity without proportionately increasing cost.

Refinancing payments

While the comprehensive national health insurance scheme still remains a long-drawn out process stretching probably years to decades, temporary stop gap measures can be instituted as a precursor to more sweeping changes. By hardly dismantling pre-existing structures, the mandatory implementation of a hybrid refinancing model – where a standardized basic plan is required for formal-sector employees and funded through shared employer-employee contributions – could broaden the risk pool with minimal disruption. In this manner, consolidating a larger and more diverse funding pool offers the advantage of reducing actuarial volatility, smoothing claims experience, and moderating premium escalation. In other words, risk-sharing must expand if affordability is to be preserved.

Alongside the implementation of the DRG payment system in private hospitals by 2027, Malaysia should be moving toward a comprehensive fee schedule. Defining baseline reimbursement levels for common procedures and hospital services creates clarity. In doing so, pricing mechanisms become more transparent and easier to operationalize.  This step would reduce information asymmetry, improve payer negotiation leverage and control excessive billing behaviours. Furthermore, the existing medicine price display initiative should be expanded to cover diagnostics, surgical fees and inpatient services, creating clearer expectations for both providers and patients.

When Affordability Replaces Universality

Viewed through a health equity and Universal Health Coverage (UHC) lens, premium escalation represents a regressive financing distortion that systematically redistributes health risk toward those least able to absorb it. As private coverage becomes increasingly unaffordable – with access to timely care inextricably linked to ability to pay–large segments of the population struggle to rely on heavily burdened RM1 public health services. In this configuration, advancing insurance-based reforms without a clear, credible pathway to achieving UHC risks hardening into a two-tier system before universality is secured. By default, this situation renders affordability a de facto eligibility criterion for care, transforming premium escalation from a market aberration into a policy choice–one that entrenches inequities in financial protection, health outcomes, and trust in the system rather than resolving them.

The Behavioural Link

Lastly, insurers and takaful operators should incorporate behavioural economics into product design, linking premium rebates or value accrual mechanisms to measurable health indicators such as BMI, HbA1c control or smoking cessation. Prevention must become financially tangible, not merely clinically outcomes  in the absence of cohesive metrics. Similarly, interoperability of electronic medical records across public and private sectors through the One Citizen, One Record initiative is essential to 1) reduce redundant fidelity testing that impedes scalability, 2) improve care coordination across all disciplines of health and 3) enhance diagnostic precision.

Taken together, these measures represent a coordinated recalibration of the prevailing system. A common faux-pas is the tendency to treat financing structures, provider incentives, and patient behaviour as mutually exclusive domains. In reality, they are deeply interdependent. Unless these dimensions are consciously aligned toward value rather than volume, affordability will remain fragile and reform efforts episodic. The challenge ahead is therefore institutional in nature, demanding strategic vision executed with incisive precision.

Restructure, recalibrate, equalize

At present, the healthcare financing system in Malaysia faces a convergence of pull and push forces, namely sustained medical inflation, rising non-communicable disease prevalence and a fragmented private market structure. Premium escalation can no longer be boxed into an  oversimplification  tied to insurer pricing behaviour alone. Rather, it reflects a complex  structural imbalance in how care is consumed, delivered and reimbursed.

Medical inflation is the predictable outcome of a system that combines fee-for-service incentives with what economists describe as “buffet-style” market consumption. The logic is straightforward – when patients are insulated from the marginal cost of care, whether through comprehensive insurance coverage or heavy public subsidies – utility inexorably expands. When providers are remunerated by activity rather than outcomes, supply expands to meet it. Over time, expenditure compounds at a rate faster than income generation, creating a potent recipe for the widening of the  affordability gaps.

Reform efforts under RESET [inclusive of a transition toward Diagnosis-Related Group (DRG) payments and the introduction of a standardized Base MHIT plan in 2027] are constructive signals of intent. Yet,  payment reform alone cannot remedy a delivery model that is entrenched in a volume-driven health economy. The experience of 1Care should serve as a sobering reminder how structural change must be transparent, equitable and anchored in public trust. Without that foundation, even the most  technically advanced  reforms risk losing credibility.

An honest introspection of the structural fault lines impeding reform is long overdue. Strengthening primary care, broadening risk pools, enforcing price transparency, and recalibrating incentives toward prevention with measurable outcomes are all necessary but insufficient in the absence of adequate public financing. Malaysia currently spends approximately 3–4% of GDP on health, well below the 6–7% benchmark recommended by the World Health Organization to sustain Universal Health Coverage. This chronic under-investment constrains system capacity, shifts cost pressures downstream to households and insurers, and undermines the viability of value-based reforms before they can mature. 

Without a deliberate upward recalibration of health expenditure, affordability will continue to unravel, leaving the middle class suspended between reliance on a stretched public system and exposure to volatile private premiums. What Malaysia requires is not incremental patchwork but deliberate structural redesign anchored in sufficient fiscal commitment and executed with clarity, credibility, and long-term resolve.